Cooper Companies (The) reported $4.24B of revenue over the trailing twelve months, +4.7% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.24B (to Q3 2026). Net income: $570M, trailing twelve months to Q3 2026. Free cash flow: $678M, trailing twelve months to Q3 2026. Operating margin: 13%, trailing twelve months to Q3 2026.

COOCooper Companies (The)

Healthcare

$54.37-19% 1Y

$54.37

$53.7052 weeks$84.32

COO as reported

Cooper Companies (The) reported $4.24B of revenue over the trailing twelve months, +4.7% on the year before. 11 reported series are charted on this page, each one as filed.

$4.24B

Revenue, trailing twelve months · to Q3 2026 · +4.7% against the twelve months before

Net income: $570M
Net income · +40% year on year · trailing twelve months to Q3 2026
Free cash flow: $678M
Free cash flow · +65% year on year · trailing twelve months to Q3 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for COO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.24B	+4.7%	Q3 2026
Net income	$570M	+40%	Q3 2026
EPS	$2.92	+43%	Q3 2026
Gross margin	66%	n/a	Q3 2026
Operating margin	13%	n/a	Q3 2026
Net margin	14%	n/a	Q3 2026
ROE	4.8%	n/a	Q3 2026
ROA	3.2%	n/a	Q3 2026
ROIC	4.3%	n/a	Q3 2026
Free cash flow	$678M	+65%	Q3 2026
P/E	18.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.